72 related articles for article (PubMed ID: 17681752)
1. 8-Prenylnaringenin, inhibits estrogen receptor-alpha mediated cell growth and induces apoptosis in MCF-7 breast cancer cells.
Brunelli E; Minassi A; Appendino G; Moro L
J Steroid Biochem Mol Biol; 2007; 107(3-5):140-8. PubMed ID: 17681752
[TBL] [Abstract][Full Text] [Related]
2. 8-Prenylnaringenin inhibits epidermal growth factor-induced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3-OH kinase activity.
Brunelli E; Pinton G; Chianale F; Graziani A; Appendino G; Moro L
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):163-70. PubMed ID: 19103290
[TBL] [Abstract][Full Text] [Related]
3. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
5. Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells.
Sakamoto T; Horiguchi H; Oguma E; Kayama F
J Nutr Biochem; 2010 Sep; 21(9):856-64. PubMed ID: 19800779
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
7. Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment.
Christoffel J; Rimoldi G; Wuttke W
J Endocrinol; 2006 Mar; 188(3):397-405. PubMed ID: 16522720
[TBL] [Abstract][Full Text] [Related]
8. Phytoestrogens induce apoptosis through a mitochondria/caspase pathway in human breast cancer cells.
Chen FP; Chien MH
Climacteric; 2014 Aug; 17(4):385-92. PubMed ID: 24299158
[TBL] [Abstract][Full Text] [Related]
9. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
10. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
Hua KT; Way TD; Lin JK
Mol Carcinog; 2006 Aug; 45(8):551-60. PubMed ID: 16637063
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio A; Di Domenico M; Castoria G; de Falco A; Bontempo P; Nola E; Auricchio F
EMBO J; 1996 Mar; 15(6):1292-300. PubMed ID: 8635462
[TBL] [Abstract][Full Text] [Related]
12. Flavonoid effects relevant to cancer.
Brownson DM; Azios NG; Fuqua BK; Dharmawardhane SF; Mabry TJ
J Nutr; 2002 Nov; 132(11 Suppl):3482S-3489S. PubMed ID: 12421874
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase.
Greger JG; Fursov N; Cooch N; McLarney S; Freedman LP; Edwards DP; Cheskis BJ
Mol Cell Biol; 2007 Mar; 27(5):1904-13. PubMed ID: 17194752
[TBL] [Abstract][Full Text] [Related]
14. Phytoestrogens in menopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model.
van Duursen MB; Smeets EE; Rijk JC; Nijmeijer SM; van den Berg M
Toxicol Appl Pharmacol; 2013 Jun; 269(2):132-40. PubMed ID: 23541764
[TBL] [Abstract][Full Text] [Related]
15. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
16. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
17. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
18. Targeting c-Src kinase enhances tamoxifen's inhibitory effect on cell growth by modulating expression of cell cycle and survival proteins.
Planas-Silva MD; Hamilton KN
Cancer Chemother Pharmacol; 2007 Sep; 60(4):535-43. PubMed ID: 17186241
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha.
Lam L; Hu X; Aktary Z; Andrews DW; Pasdar M
Breast Cancer Res Treat; 2009 Dec; 118(3):605-21. PubMed ID: 19002577
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling.
Varma H; Conrad SE
Cancer Res; 2002 Jul; 62(14):3985-91. PubMed ID: 12124331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
